Departamento de Química, Universidade Federal de São Carlos, 13565-905 São Carlos (SP), Brazil.
Eur J Med Chem. 2010 Jul;45(7):2847-53. doi: 10.1016/j.ejmech.2010.03.005. Epub 2010 Mar 11.
Complexes [RuCl(H4NO(2)Fo4M)(bipy)(dppb)]PF(6) (1), [RuCl(H4NO(2)Fo4M)(Mebipy)(dppb)]PF(6) (2), [RuCl(H4NO(2)Fo4M)(phen)(dppb)]PF(6) (3), [RuCl(H4NO(2)Ac4M)(bipy)(dppb)]PF(6) (4), [RuCl(H4NO(2)Ac4M)(Mebipy)(dppb)]PF(6) (5) and [RuCl(H4NO(2)Ac4M)(phen)(dppb)]PF(6) (6) with N(4)-methyl-4-nitrobenzaldehyde thiosemicarbazone (H4NO(2)Fo4M) and N(4)-methyl-4-nitroacetophenone thiosemicarbazone (H4NO(2)Ac4M) were obtained from [RuCl(2)(bipy)(dppb)], [RuCl(2)(Mebipy)(dppb)], and [RuCl(2)(phen)(dppb)], (dppb = 1,4-bis(diphenylphospine)butane; bipy = 2,2'-bipyridine; Mebipy = 4,4'-dimethyl-2,2'-bipyridine; phen = 1,10-phenanthroline). In all cases the thiosemicarbazone is attached to the metal center through the sulfur atom. Complexes (1-6), together with the corresponding ligands and the Ru precursors were evaluated for their ability to in vitro suppress the growth of Trypanosoma cruzi. All complexes were more active than their corresponding ligands and precursors. Complexes (1-3) and (5) revealed to be the most active among all studied compounds with ID(50) = 0.6-0.8 microM. In all cases the association of the thiosemicarbazone with ruthenium, dppb and bipyridine or phenanthroline in one same complex proved to be an excellent strategy for activity improvement.
具有硫代缩氨基脲配体的新型六核钌(III)配合物的合成、晶体结构及抗克氏锥虫活性
复合物 [RuCl(H4NO(2)Fo4M)(bipy)(dppb)]PF(6)(1)、[RuCl(H4NO(2)Fo4M)(Mebipy)(dppb)]PF(6)(2)、[RuCl(H4NO(2)Fo4M)(phen)(dppb)]PF(6)(3)、[RuCl(H4NO(2)Ac4M)(bipy)(dppb)]PF(6)(4)、[RuCl(H4NO(2)Ac4M)(Mebipy)(dppb)]PF(6)(5)和[RuCl(H4NO(2)Ac4M)(phen)(dppb)]PF(6)(6)是通过[RuCl(2)(bipy)(dppb)]、[RuCl(2)(Mebipy)(dppb)]和[RuCl(2)(phen)(dppb)]与 N(4)-甲基-4-硝基苯甲醛缩氨基脲(H4NO(2)Fo4M)和 N(4)-甲基-4-硝基苯乙酮缩氨基脲(H4NO(2)Ac4M)反应得到的,(dppb = 1,4-双(二苯基膦)丁烷;bipy = 2,2'-联吡啶;Mebipy = 4,4'-二甲基-2,2'-联吡啶;phen = 1,10-菲啰啉)。在所有情况下,缩氨基脲都是通过硫原子连接到金属中心的。将复合物(1-6)以及相应的配体和 Ru 前体进行了体外抑制 Trypanosoma cruzi 生长能力的评估。所有复合物的活性均强于相应的配体和前体。复合物(1-3)和(5)是所有研究化合物中最活跃的,ID(50)为 0.6-0.8 μM。在所有情况下,将硫代缩氨基脲与钌、dppb 和联吡啶或菲啰啉结合在同一个复合物中,都被证明是提高活性的绝佳策略。